Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rheumatoid arthritis in the developing world.

Asgar Ali Kalla1, Mohammed Tikly

  • 1Division of Rheumatology, Department of Medicine, Groote Schuur Hospital and University of Cape Town, J47 Old Main Building, Observatory, Cape Town 7925, South Africa. kallaa@iafrica.com

Best Practice & Research. Clinical Rheumatology
|August 14, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Item selection for the development and validation of a revised classification criteria for adult and juvenile idiopathic inflammatory myopathies: MyoROC project.

Seminars in arthritis and rheumatism·2025
Same author

Clinical and Serological Correlates of Serum C1Q and Anti-C1Q Antibodies in South Africans With Systemic Lupus Erythematosus.

Journal of clinical laboratory analysis·2025
Same author

The TFIID complex is a new autoantibody target in systemic sclerosis.

Annals of the rheumatic diseases·2025
Same author

Physician perceptions of challenges and barriers to optimal care of systemic lupus erythematosus in Africa.

Lupus·2025
Same author

Challenges in Diagnosis and Management of SLE in Africa: An Online Survey.

ACR open rheumatology·2024
Same author

Patient journey, disease burden, and functional disability in patients with axial spondyloarthritis in South Africa: results of International Map of Axial Spondyloarthritis (IMAS).

Clinical rheumatology·2024
Same journal

The young adult with Juvenile Idiopathic Arthritis (JIA): A clinical review of transition, complications, and psychosocial management.

Best practice & research. Clinical rheumatology·2026
Same journal

Impact of fatigue on rheumatic diseases: Current perspectives.

Best practice & research. Clinical rheumatology·2026
Same journal

Pneumocystis prophylaxis in rheumatic disease.

Best practice & research. Clinical rheumatology·2026
Same journal

Cutaneous manifestations in myositis syndromes.

Best practice & research. Clinical rheumatology·2026
Same journal

Systemic sclerosis: A comprehensive systematic review of global epidemiology, sex and ethnic disparities, disease burden, and organ-specific involvement.

Best practice & research. Clinical rheumatology·2026
Same journal

Alopecia across the spectrum of rheumatic disease.

Best practice & research. Clinical rheumatology·2026
See all related articles

Rheumatoid arthritis (RA) may be less common in developing nations, but severe cases pose a significant challenge due to limited resources. Focus should be on early, aggressive treatment with disease-modifying anti-rheumatic drugs (DMARDs) and glucocorticoids.

Area of Science:

  • Rheumatology
  • Global Health
  • Epidemiology

Background:

  • Rheumatoid arthritis (RA) is often perceived as having lower prevalence and milder disease course in developing countries.
  • Epidemiological data suggest a correlation between RA prevalence and urbanization levels.
  • Severe RA disability in resource-limited settings presents a substantial healthcare challenge.

Purpose of the Study:

  • To explore the epidemiological patterns of rheumatoid arthritis in developing countries.
  • To evaluate the challenges and therapeutic strategies for rheumatoid arthritis in resource-limited settings.
  • To guide future research directions for managing rheumatoid arthritis in poorer communities.

Main Methods:

  • Review of epidemiological studies on rheumatoid arthritis prevalence across different global regions.

Related Experiment Videos

  • Analysis of disease burden and impact in developing countries with scarce medical resources.
  • Assessment of current and potential future therapeutic interventions for rheumatoid arthritis.

    • Main Results:

    • Varying RA prevalence possibly linked to urbanization.
    • Significant disability burden in developing countries due to limited resources.
    • Concerns regarding the cost and safety (e.g., infection risk) of advanced therapies like TNF-alpha blockers in these regions.

    Conclusions:

    • Future research should prioritize assessing the disease burden of RA in developing nations.
    • Early, aggressive treatment with DMARDs and glucocorticoids is recommended for most RA patients.
    • Targeted biological therapies should be explored via clinical trials and compassionate use programs for refractory cases.